Search
About Wistar Research & Facilities Education & Training Technology Transfer Ways of Giving News & Information
         
 


Overview
Licensing Opportunities
Technologies
Research Tools
Patents
By Inventor
Material Transfers
Guidelines for Inventors
Contact Us
     

Monoclonal Antibodies to ADAR

Inventor: Kazuko Nishikura

Tech ID: NK9480, NK0701RR, NK0702RR, NK0703RR

Description:Adenosine Deaminase Acting on RNA (ADAR) is a member of a gene family that is involved in site-selective RNA editing that changes adenosine residues to inosine.  Three vertebrate ADAR gene family members, ADAR1, ADAR2,and ADAR3, have been identified.  ADAR1 and ADAR2 form a stable enzymatically active homodimer complex and ADAR3 is a monomeric, enzymatically inactive form.

anti-ADAR1 (made against dsRNA binding domain region)

Clone

Isotype

Tested In

 

 

 

15.8.6

IgG

Western Blot & Immunohistochemistry

References:    Q. Wang et al.  (2000)  Requirement of the RNA Editing Deaminase ADAR1 Gene for Embryonic Erythropoiesis, Science Vol. 290, 1765-1768

                        Dan-Sung C. Cho et al. (2003)  Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA, The Journal of Biological Chemistry Vol. 278 No. 19, 17093-17102

anti-ADAR2 (made against N-terminal region)

Clone

Isotype

Tested In

 

 

 

1.3.1

IgG

Western Blot & Immunohistochemistry

References:    Dan-Sung C. Cho et al. (2003)  Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA, The Journal of Biological Chemistry Vol. 278 No. 19, 17093-17102

anti-ADAR3 (made against N-terminal region)

Clone

Isotype

Tested In

 

 

 

3.591

IgG

Western Blot

References:    Chun-Xia Chen et al.  (2000)  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains, RNA Vol. 6, 755-767

Licensing Opportunity: These antibodies are available for non-exclusive license for research use.

Key Words: ADAR, adenosine deaminase, RNA Editing

Contact:
Meryle J. Melnicoff, Ph.D.
Director, Business Development
The Wistar Institute
Phone: (215) 898-0049
melnicoff@wistar.org

Last updated: Jan-07

 

 

Kazuko Nishikura, Ph.D.

 

Contact Us

Meryle Melnicoff, PhD
Director, Business Development

Christopher Harold Croft
Administrative Coordinator

 

  © 2007 The Wistar Institute | Terms of Use